FDA stops pediatric trials of Amgen drug after teen death

02/26/2013 | Reuters · CBS News

The FDA announced on Tuesday the termination of all pediatric clinical trials of Amgen's thyroid drug Sensipar following the death of a 14-year-old patient. Officials said they are still gathering information surrounding the teen's death and they remain uncertain if the drug played a role in the death.

View Full Article in:

Reuters · CBS News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR